These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
671 related articles for article (PubMed ID: 28077323)
1. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells. Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323 [TBL] [Abstract][Full Text] [Related]
2. High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells. Xue M; Li Y; Hu F; Jia YJ; Zheng ZJ; Wang L; Xue YM Biochem Biophys Res Commun; 2018 Mar; 498(1):38-44. PubMed ID: 29371016 [TBL] [Abstract][Full Text] [Related]
3. miR-192 prevents renal tubulointerstitial fibrosis in diabetic nephropathy by targeting Egr1. Liu F; Zhang ZP; Xin GD; Guo LH; Jiang Q; Wang ZX Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4252-4260. PubMed ID: 30024615 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma. Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931 [TBL] [Abstract][Full Text] [Related]
5. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy. Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566 [TBL] [Abstract][Full Text] [Related]
6. Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells. Wang D; Guan MP; Zheng ZJ; Li WQ; Lyv FP; Pang RY; Xue YM Cell Physiol Biochem; 2015; 36(6):2093-107. PubMed ID: 26279418 [TBL] [Abstract][Full Text] [Related]
7. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy. Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287 [TBL] [Abstract][Full Text] [Related]
9. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway. Zhang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484 [TBL] [Abstract][Full Text] [Related]
10. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
11. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4 axis. Zha F; Qu X; Tang B; Li J; Wang Y; Zheng P; Ji T; Zhu C; Bai S Aging (Albany NY); 2019 Jun; 11(11):3716-3730. PubMed ID: 31195367 [TBL] [Abstract][Full Text] [Related]
13. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease. Wang Y; Zheng ZJ; Jia YJ; Yang YL; Xue YM J Transl Med; 2018 May; 16(1):146. PubMed ID: 29848325 [TBL] [Abstract][Full Text] [Related]
14. Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions. Park JT; Kato M; Lanting L; Castro N; Nam BY; Wang M; Kang SW; Natarajan R Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1390-403. PubMed ID: 25354942 [TBL] [Abstract][Full Text] [Related]
15. A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kato M; Arce L; Wang M; Putta S; Lanting L; Natarajan R Kidney Int; 2011 Aug; 80(4):358-68. PubMed ID: 21389977 [TBL] [Abstract][Full Text] [Related]
16. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy. Kang WL; Xu GS Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039 [TBL] [Abstract][Full Text] [Related]
17. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1. Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483 [TBL] [Abstract][Full Text] [Related]
18. miR-23a-3p regulates the inflammatory response and fibrosis in diabetic kidney disease by targeting early growth response 1. Sheng S; Zou M; Yang Y; Guan M; Ren S; Wang X; Wang L; Xue Y In Vitro Cell Dev Biol Anim; 2021 Sep; 57(8):763-774. PubMed ID: 34608568 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1. Ma J; Zhang L; Hao J; Li N; Tang J; Hao L J Pharmacol Sci; 2018 Apr; 136(4):218-227. PubMed ID: 29551286 [TBL] [Abstract][Full Text] [Related]
20. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression. Wang Y; Le Y; Xue JY; Zheng ZJ; Xue YM Biochem Biophys Res Commun; 2016 Oct; 479(4):676-682. PubMed ID: 27693697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]